灵活的DCT技术，您可以信任的经验
IQVIA Patient Engagement Suite offers flexible, configurable, scalable technology products that improve patient experience, reduce site burden, and decrease study timelines for better trial outcomes. Learn why IQVIA’s hybrid DCT solutions have been used more than any others.1
1行业标准研究，2021年
以设计为中心
Built by one of biopharma’s most trusted decentralized trials solution providers, IQVIA Decentralized Clinical Trials Platform was designed to address some of the most common challenges in hybrid trials, including:
- Integration with patient recruitment
- Improved patient engagement
- 增加学习团队合作
- 简化端点数据流
With this platform, IQVIA aims to empower any sponsor to deploy adaptable, patient-centric DCT technology for any study and any indication – anywhere on the globe.
行业领先的混合解决方案
〜67％的行业专家中，IQVIA是混合试验解决方案提供商中的领导者 - 比任何其他技术或服务提供商都多40多个国家的90项研究
IQVIA分散试验solutions> 210k受试者已注册
在30多个指示的IQVIA分散试验中
Built on a foundation of deep clinical operations knowhow
DCT不仅需要技术。IQVIA拥有临床操作专有技术，治疗专业知识和全球范围，以确保赞助商从我们的技术解决方案中获得最大价值。
我们的DCT产品包括专门的学习团队，访问参与者的家的研究护士以及连接DCT生态系统的技术 - 从Econcent and Irt，ECOA到ECOA以及连接的设备。
IQVIA分散试验and Technology Suite delivers the adaptability and scale to meet any sponsor’s requirements – small or large, local or global.
Power your decentralized trial with an agile randomization and trial supply management solution that supports supply flexibility and optimization as well as adaptable direct to patient options.
Deliver eConsent to sites and study participants around the globe with confidence
Discover intelligent insights from streamlined data and sophisticated analytics to transform trial workflows.